Free tool
FAERS Monitor: Verapamil Hydrochloride
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018925 or its brand name (Verapamil Hydrochloride, Verapamil Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
4,312
Serious
3,916
91% of reports
Hospitalization
1,954
Death reported
958
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dyspnoea357
- nausea353
- drug interaction316
- dizziness293
- hypotension287
- fatigue277
- diarrhoea271
- abdominal pain245
- vomiting244
- cough242
- headache238
- fall237
- completed suicide236
- tachycardia230
- asthenia229
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 82 |
| 2005 | 130 |
| 2006 | 122 |
| 2007 | 58 |
| 2008 | 90 |
| 2009 | 53 |
| 2010 | 86 |
| 2011 | 79 |
| 2012 | 112 |
| 2013 | 61 |
| 2014 | 109 |
| 2015 | 160 |
| 2016 | 187 |
| 2017 | 187 |
| 2018 | 199 |
| 2019 | 217 |
| 2020 | 243 |
| 2021 | 273 |
| 2022 | 488 |
| 2023 | 407 |
| 2024 | 438 |
| 2025 | 331 |
| 2026 | 200 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,847 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| completed suicideSignal | 236 | 13.9 | 12.2 | 2,804 |
| tachycardiaSignal | 230 | 12.7 | 11.2 | 2,462 |
| drug interactionSignal | 316 | 9.7 | 8.8 | 2,481 |
| hypotensionSignal | 287 | 7.0 | 6.2 | 1,478 |
| abdominal painSignal | 245 | 5.1 | 4.6 | 821 |
| coughSignal | 242 | 4.2 | 3.7 | 597 |
| fallSignal | 237 | 3.5 | 3.1 | 422 |
| dyspnoeaSignal | 357 | 3.1 | 2.8 | 512 |
| astheniaSignal | 229 | 3.0 | 2.6 | 303 |
| dizzinessSignal | 293 | 2.9 | 2.6 | 363 |
| vomitingSignal | 244 | 2.5 | 2.2 | 230 |
| nauseaSignal | 353 | 2.2 | 2.0 | 232 |
| diarrhoeaSignal | 271 | 2.0 | 1.8 | 149 |
| headache | 238 | 1.9 | 1.6 | 95 |
| fatigue | 277 | 1.7 | 1.5 | 89 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.